How many shares of REGN does Amundi own?

As of 2026-Q2, Amundi holds 1M shares of REGN (REGENERON PHARMACEUTICALS).

What is Amundi's REGN position worth?

As of 2026-Q2, Amundi's REGN position is worth $632M.

In 2026-Q2, Amundi increased their REGN position (+0.4% change in shares).

Based on available 13F filings, Amundi first reported a position in REGN in 2021-Q2. They have held the position across 21 quarters.

Position history for Amundi's holdings in REGENERON PHARMACEUTICALS

Current Value

$632M

Current Shares

Total Value Change

+$519.5M

Total Shares Change

+812,121

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1M	+0.4%	$632M	0.2%	$622.81	38
2026-Q1	Increased	1M	+27.5%	$780.2M	0.2%	$770.59	47
2025-Q4	Increased	791,906	+27.4%	$611.2M	0.2%	$768.90	47
2025-Q3	Decreased	621,741	-30.7%	$364M	0.1%	$559.40	0
2025-Q2	Decreased	897,131	-44.1%	$491.4M	0.2%	$521.53	0
2025-Q1	Increased	1.6M	+3.4%	$979.8M	0.4%	$629.11	39
2024-Q4	Increased	1.6M	+45.8%	$1.1B	0.4%	$705.67	52
2024-Q3	Decreased	1.1M	-0.0%	$1.1B	0.4%	$1,041.41	0
2024-Q2	Increased	1.1M	+0.7%	$1.1B	0.4%	$1,041.20	38
2024-Q1	Increased	1.1M	+15.6%	$944.6M	0.4%	$953.49	44
2023-Q4	Increased	914,125	+33.4%	$825.1M	0.4%	$870.08	49
2023-Q3	Increased	685,286	+0.1%	$575.4M	0.3%	$815.27	37
2023-Q2	Decreased	684,712	-11.3%	$491.7M	0.2%	$711.82	0
2023-Q1	Increased	772,215	+11.0%	$637.2M	0.3%	$813.99	42
2022-Q4	Increased	695,435	+6.1%	$493.7M	0.3%	$714.75	40
2022-Q3	Increased	655,190	+18.2%	$488.5M	0.3%	$682.43	44
2022-Q2	Increased	554,508	+11.1%	$332.1M	0.3%	$585.60	41
2022-Q1	Increased	498,930	+8.4%	$360.1M	0.2%	$691.89	40
2021-Q4	Increased	460,330	+7.9%	$283.6M	0.2%	$625.62	40
2021-Q3	Increased	426,457	+111.7%	$258.1M	0.2%	$599.52	59
2021-Q2	New	201,419	-	$112.5M	0.1%	$553.32	42